AbbVie, Inc. (ABBV)
264.02
+1.51
(+0.58%)
USD |
NYSE |
Sep 17, 16:00
262.13
-1.89
(-0.72%)
Pre-Market: 07:37
AbbVie 30-Day Average Daily Volume : 4.313M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 4.313M |
| September 16, 2026 | 4.369M |
| September 15, 2026 | 4.533M |
| September 14, 2026 | 4.610M |
| September 11, 2026 | 4.702M |
| September 10, 2026 | 4.772M |
| September 09, 2026 | 4.811M |
| September 08, 2026 | 4.917M |
| September 04, 2026 | 4.912M |
| September 03, 2026 | 4.894M |
| September 02, 2026 | 4.952M |
| September 01, 2026 | 4.976M |
| August 31, 2026 | 5.008M |
| August 28, 2026 | 5.008M |
| August 27, 2026 | 5.130M |
| August 26, 2026 | 5.190M |
| August 25, 2026 | 5.292M |
| August 24, 2026 | 5.345M |
| August 21, 2026 | 5.354M |
| August 20, 2026 | 5.375M |
| August 19, 2026 | 5.385M |
| August 18, 2026 | 5.453M |
| August 17, 2026 | 5.560M |
| August 14, 2026 | 5.691M |
| August 13, 2026 | 5.789M |
| Date | Value |
|---|---|
| August 12, 2026 | 5.876M |
| August 11, 2026 | 5.983M |
| August 10, 2026 | 6.159M |
| August 07, 2026 | 7.773M |
| August 06, 2026 | 7.952M |
| August 05, 2026 | 8.043M |
| August 04, 2026 | 8.115M |
| August 03, 2026 | 8.178M |
| July 31, 2026 | 8.252M |
| July 30, 2026 | 8.197M |
| July 29, 2026 | 8.182M |
| July 28, 2026 | 8.172M |
| July 27, 2026 | 8.073M |
| July 24, 2026 | 8.045M |
| July 23, 2026 | 8.043M |
| July 22, 2026 | 8.031M |
| July 21, 2026 | 8.030M |
| July 20, 2026 | 8.078M |
| July 17, 2026 | 8.159M |
| July 16, 2026 | 8.119M |
| July 15, 2026 | 8.096M |
| July 14, 2026 | 8.045M |
| July 13, 2026 | 8.124M |
| July 10, 2026 | 8.159M |
| July 09, 2026 | 8.121M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Biogen, Inc. | 739073.4 |
| Gilead Sciences, Inc. | 5.607M |
| Regeneron Pharmaceuticals, Inc. | 656937.0 |
| Amgen, Inc. | 2.520M |
| REGENXBIO, Inc. | 1.280M |